These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6897455)

  • 1. [1,5-dicoffeechinic acid in the treatment of hypertriglyceridemia].
    Wojcicki J; Olejak B; Pieczul-Mróz J; Torbus-Lisiecka B; Bukowska H; Gregorczyk J
    Przegl Lek; 1982; 39(9):601-6. PubMed ID: 6897455
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of bezafibrate on lipid and apoprotein levels in patients with idiopathic hypertriglyceridemia].
    Naruszewicz M; Nowicka G; Szostak WB; Kłosiewicz-Latoszek L
    Kardiol Pol; 1982; 25(7-8):527-31. PubMed ID: 7169740
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plafibride treatment of hyperlipidemias type II and IV].
    Soler J; Vinzia C; Gómez JM; Morató J
    Med Clin (Barc); 1984 May; 82(19):840-2. PubMed ID: 6738212
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood coagulation and fibrinolysis systems in patients with hypertriglyceridemia treated with 1,5-dicoffeechinic acid].
    Borodin M; Jurek D; Gregorczyk J; Wójcicki J; Olejak B; Pieczul-Mróz J
    Przegl Lek; 1982 Sep; 39(8):525-32. PubMed ID: 6897121
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term therapy of type II and type IV hyperlipoproteinemia using beclobrate].
    Uglesić A; Ljachnicky N
    Schweiz Rundsch Med Prax; 1988 Jul; 77(27-28):755-61. PubMed ID: 3041534
    [No Abstract]   [Full Text] [Related]  

  • 6. [Phospholipid fractions and free fatty acids in the serum of patients with hypertriglyceridemia treated with 1,5-dicaffeequinine acid].
    Wesołowska T; Szmatłoch E; Wira D; Pieczul-Mróz J; Gregorczyk J
    Przegl Lek; 1986; 43(7):527-30. PubMed ID: 3775065
    [No Abstract]   [Full Text] [Related]  

  • 7. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
    Lopez Rodriguez J; Martorell J
    Clin Ther; 1980; 3(4):234-41. PubMed ID: 7273061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.
    Crepaldi G; Fellin R; Calabrò A; Baiocchi MR; Rossi A; Lenzi S; Descovich GC; Delmonte G; Gaddi A; Ventura A
    Monogr Atheroscler; 1986; 14():215-21. PubMed ID: 3526129
    [No Abstract]   [Full Text] [Related]  

  • 9. Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype.
    Bermúdez-Pirela V; Souki A; Cano-Ponce C; Bermúdez-Arias F; Mengual-Moreno E; Leal-Gonzalez E; Lemus-Antepaz M; de Bravo MC; de Díaz AA; de Pirela NL; Cano-Peñaloza R; Puche-Medina G; Arraiz N; Reyna-Villazmil N; Contreras F; Israili ZH; Valasco M
    Am J Ther; 2007; 14(2):213-20. PubMed ID: 17414592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of gemfibrozil on serum lipid levels.
    Dahlén G; Gillnäs T; Børresen AL; Berg K; Ericson C
    Artery; 1980; 7(3):224-31. PubMed ID: 7008748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental and clinical studies on the hypolipemic action of 1,5-dicaffeoylquinic acid].
    Wójcicki J; Bobnis W; Olszewska M; Szmatloch E
    Pol Tyg Lek; 1974 Apr; 29(15):627-9. PubMed ID: 4828046
    [No Abstract]   [Full Text] [Related]  

  • 12. [Double-blind study of the therapeutic activity of a new hypolipemic drug: etofibrate].
    Altomonte L; Mingrone G; Negrini A; De Cunto F; Greco AV
    Clin Ter; 1981 Jan; 96(1):31-8. PubMed ID: 7016409
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rapid changes in blood lipid parameters induced by glucuronyl glucosamine glycan sulfate in obese diabetic and hyperlipidemia patients].
    Ferlito S; La Spina E; Fichera C; Cultrera E; Patanè M; Ciulla P
    Arch Sci Med (Torino); 1982; 139(4):441-8. PubMed ID: 7168636
    [No Abstract]   [Full Text] [Related]  

  • 14. [Disorders of lipid metabolism--diagnosis and therapy in general practice. 7: Treatment of increased triglycerides].
    Richter WO
    Fortschr Med; 1996 Jun; 114(17):229-30. PubMed ID: 8767301
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of bezafibrate and fenofibrate on elevated blood lipids in HLP type IIa, IIb and IV].
    Schwartzkopff W; Luley C; Scheffler W; Lehmann-Leo W; Schilling A; Wegscheider K
    Med Welt; 1982 Apr; 33(17):631-7. PubMed ID: 7098826
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antilipemic effect of bezafibrate in patients with hyperlipoproteinemia type IV].
    Chwistecki K; Mrukowicz M; Kopel E
    Wiad Lek; 1985 Apr; 38(7):490-4. PubMed ID: 4013323
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of hypertriglyceridemia and its treatment on tetracycline pharmacokinetics].
    Gawrońska-Szklarz B; Kalinowski W; Wójcicki J
    Pol Tyg Lek; 1984 Feb; 39(9):295-8. PubMed ID: 6473210
    [No Abstract]   [Full Text] [Related]  

  • 18. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
    Domingo AJ; Gutiérrez JA; Menéndez JA; Micó L; Muñoz M; de Oya M
    Clin Ther; 1980; 3(3):219-26. PubMed ID: 7459931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemfibrozil--a new lipid lowering agent.
    Nash DT
    J Med; 1980; 11(2-3):107-16. PubMed ID: 6931871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Excessive hypertriglyceridemia and pancreatitis in a 17-year-old pregnant patient].
    Scheffler E; Kather H; Schlierf G; Ziegler R
    Internist (Berl); 1991 Jun; 32(6):354-5. PubMed ID: 1880014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.